Skip to main content
Signal8

Tsai Philip

SEC insider (Form 3/4/5 filer). CIK 0002026600. Chief Technical Officer at Immunome Inc. (IMNM). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 23, 2026. Located in BOTHELL, WA.

Companies Tsai Philip has filed insider reports for

  • Immunome Inc. (IMNM): Officer, Chief Technical Officer
Tsai Philip profile photo

Tsai Philip

CIK: 0002026600

Transaction Breakdown

Open Market Buys (P)3 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immunome Inc. logo
IMNM

Immunome Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Immunome Inc. logo
    IMNM

    Immunome Inc.

    Jul 23, 2026
    Award
    Direct
    38.3K shares-
  • Immunome Inc. logo
    IMNM

    Immunome Inc.

    Dec 19, 2025
    Purchase
    Direct
    10K shares at avg. $20.49$205K
  • Immunome Inc. logo
    IMNM

    Immunome Inc.

    Jul 29, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    190K shares-
  • Immunome Inc. logo
    IMNM

    Immunome Inc.

    Mar 24, 2025
    Purchase
    Direct
    12.3K shares at avg. $8.42$104K
  • Immunome Inc. logo
    IMNM

    Immunome Inc.

    Nov 21, 2024
    Purchase
    Direct
    21K shares at avg. $9.43$198K

1-5 of 5